ArticleTranslational vision science & technology2025
Unilateral Visual Impairment and Increased Mortality: The UK Biobank Cohort Study.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combined effects of depression and visual impairment on cardiovascular disease incidence in a Chinese population-based cohort.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to investigate the association between the full spectrum of visual acuity categories and risks of all-cause, cardiovascular disease (CVD)-related, cancer-related mortality in the UK Biobank study. Methods: A total of 131,468 participants (aged 40-79 years) with visual acuity measurement from the UK Biobank prospective cohort were included. Visual acuities of both eyes were used to assign each participant into one of the following groups: bilateral normal, unilateral near normal, bilateral near normal, unilateral visual impairment (VI), mild VI, and low vision. Cox proportional hazards multivariable regression models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for the risks of all-cause, CVD-related, and cancer-related mortality. Results: Over a median follow-up of 13.49 years, a total of 9372 deaths were recorded, including 4682 cancer-related deaths and 1926 CVD-related deaths. Compared with the bilateral normal group, participants with decreased visual acuity had increased risks of all-cause and CVD-related mortality with dose-response-type gradients, but no elevated risk of cancer-related mortality was observed. Decreased unilateral visual acuity but not bilateral near normal vision was associated with increased risks for all-cause and CVD-related mortality. For all-cause and CVD-related mortality, the adjusted HRs were 1.17 (95% CI = 1.09-1.25) and 1.24 (95% CI = 1.07-1.44) for the unilateral near normal group, and 1.20 (95% CI = 1.14-1.27) and 1.26 (95% CI = 1.12-1.42) for the unilateral VI group. Conclusions: Decreased unilateral visual acuity was associated with increased all-cause and CVD-related mortality risks among participants without VI in the UK Biobank. Translational Relevance: Achieving bilateral vision balance may contribute to reducing the mortality risk of individuals with decreased unilateral visual acuity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.